Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05419765
What this trial is testing

Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Roma La Sapienza 316
Not applicableStudy completedNCT02148471
What this trial is testing

Fatty Acids, Genes and Microbiota in Fatty Liver

Who this might be right for
Nonalcoholic Fatty Liver DiseaseSteatosisNonalcoholic Steatohepatitis
Johane Allard 205
Not applicableUnknownNCT06304844
What this trial is testing

Risk of CKD in Diabetic Patients With MAFLD

Who this might be right for
Type 2 Diabetes
Sohag University 300
Not applicableStudy completedNCT03211299
What this trial is testing

Determinants of Liver Fat Composition

Who this might be right for
Fatty Liver, NonalcoholicInsulin Sensitivity
Maastricht University Medical Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Not applicableUnknownNCT03156881
What this trial is testing

Global Osteopathic Treatment for Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Jenna Wilcox 48
Not applicableNot Yet RecruitingNCT05857319
What this trial is testing

Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)

Who this might be right for
Overweight and ObesityCardiovascular DiseasesMetabolic Disease+4 more
Groupe Éthique et Santé 10,000
Not applicableStudy completedNCT01264198
What this trial is testing

The Role of Resistance Training in Non Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD (Non-Alcoholic Fatty Liver Disease)Resistance Training
Tel-Aviv Sourasky Medical Center 82
Testing effectiveness (Phase 2)UnknownNCT05084404
What this trial is testing

Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Yokohama City University 29
Not applicableStudy completedNCT04281121
What this trial is testing

Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver

Who this might be right for
Fatty Liver
Ain Shams University 60
Early research (Phase 1)Study completedNCT04193436
What this trial is testing

COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT

Who this might be right for
Hepatic ImpairmentHealthy Participants
Pfizer 23
Large-scale testing (Phase 3)Looking for participantsNCT06493799
What this trial is testing

In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

Who this might be right for
Chronic Liver Disease
Green Cross Wellbeing 226
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Large-scale testing (Phase 3)Study completedNCT07278128
What this trial is testing

Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial

Who this might be right for
Polycystic Ovary Syndrome (PCOS) With Concurrent Nonalcoholic Fatty Liver Disease (NAFLD)
Fateme Moshirenia 74
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Not applicableStudy completedNCT05309642
What this trial is testing

Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Ewha Womans University Mokdong Hospital 72
Early research (Phase 1)Study completedNCT03744182
What this trial is testing

Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD

Who this might be right for
NAFLD
Hanmi Pharmaceutical Company Limited 66
Not applicableStudy completedNCT07175688
What this trial is testing

Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients

Who this might be right for
Metabolic Associated Fatty Liver DiseasePancreatic SteatosisObese+2 more
Tanta University 217
Not applicableUnknownNCT02285218
What this trial is testing

Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD

Who this might be right for
Non-alcoholic Fatty Liver DiseaseType 2 DiabetesMetabolic Syndrome
Yonsei University 200
Not applicableStudy completedNCT05426382
What this trial is testing

A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Sidekick Health 38
Next Page